Insmed | INSM - Spese Operative

Prezzo Delle Azioni
146.73
Cambio Giornaliero
-6.67 -4.35%
Mensile
1.47%
Annuale
109.02%
Q2 Previsione
150.58




Spese Operative Cambiamento Data
BioMarin Pharmaceutical USD 676.18M 131.65M 2025-12
Cytokinetics USD 196.12M 27.43M 2025-12
DBV Technologies USD 37.05M 4.06M 2025-09
Gilead Sciences USD 4.96B 707M 2025-12
Heron Therapeutics USD 40.55M 1.46M 2025-12
Insmed USD 513.55M 109.86M 2025-12
Novartis USD 9.8B 23M 2025-12
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Sarepta Therapeutics USD 853.02M 390.78M 2025-12
Ultragenyx Pharmaceutical USD 321M 9.82M 2025-12
Vertex Pharmaceuticals USD 1.93B 89.1M 2025-12